Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | |
Div Cover | n/a | |
Op Mrgn | 1.4% | |
ROCE | 9.8% |
Latest | F'cast | |
---|---|---|
P/E | 408.2 | |
PEG | n/a | |
Pr/Revenue | 3.0 | |
Pr/Book | 3.6 |
Latest | F'cast | |
---|---|---|
Revenue | 14.8% | |
PBT | -62.0% | |
EPS | -94.0% | |
DPS | n/a |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | 2,666.70 | (232.22) | (136.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 2,986.27 | 570.44 | 430.00¢ | 17.1 | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 3,394.64 | 529.12 | 153.00¢ | 52.5 | n/a | -64% | n/a | 0.0% |
31-Dec-23 | 3,695.65 | 834.22 | 267.00¢ | 23.5 | 0.3 | +74% | n/a | 0.0% |
31-Dec-24 | 4,241.22 | 316.63 | 16.00¢ | 431.7 | n/a | -94% | n/a | 0.0% |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 4,834.18 | 1,491.28 | 620.30¢ | 13.9 | 0.0 | +3,777% | n/a | 0.0% |
31-Dec-26 | 5,369.81 | 1,843.34 | 732.21¢ | 11.8 | 0.7 | +18% | n/a | 0.0% |
31-Dec-27 | 5,882.11 | 2,276.93 | 889.49¢ | 9.7 | 0.5 | +22% | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
FDA grants EUA for Eli Lilly treatment in conjun... | 20-Nov-2020 | ShareCast |
Currency | US Dollars |
Share Price | $ 86.70 |
Change Today | $ 0.50 |
% Change | 0.58 % |
52 Week High | $86.97 |
52 Week Low | $55.11 |
Volume | 422,914 |
Shares Issued | 193.43m |
Market Cap | $16,771m |
RiskGrade | 196 |
Strong Buy | 8 |
Buy | 4 |
Neutral | 11 |
Sell | 2 |
Strong Sell | 0 |
Total | 25 |
Time | Volume / Share Price |
14:15 | 100 @ $86.70 |
14:15 | 100 @ $86.72 |
14:15 | 100 @ $86.72 |
14:14 | 100 @ $86.73 |
14:14 | 100 @ $86.73 |
You are here: research